Stebbing, 1990 - Google Patents
Proteins as Therapeutics: Potential and ProblemsStebbing, 1990
- Document ID
- 2508573124042823884
- Author
- Stebbing N
- Publication year
- Publication venue
- Protein Production by Biotechnology
External Links
Snippet
Many of the recombinant DNA systems of current interest for production of therapeutic proteins have been covered in preceding chapters. Progress in recent years has been rapid; genes for the first proteins of clinical interest were cloned and expressed in Escherichia coli …
- 102000004169 proteins and genes 0 title abstract description 85
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI227140B (en) | Therapeutic agent for cachexia comprising a substance capable of inhibiting the binding between a parathyroid hormone related peptide and a receptor thereof as an active ingredient | |
US5716934A (en) | Eck receptor ligands | |
Bonni et al. | Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus | |
US11952432B2 (en) | Cell-permeable stapled peptide modules for cellular delivery | |
KR100581798B1 (en) | antibodies against interferon alpha/beta receptor having ability for selectively blocking interferon alpha | |
JPH06510202A (en) | hybrid cytokine | |
DE69900756T2 (en) | USE OF HMG PROTEINS FOR THE PRODUCTION OF MEDICINAL PRODUCTS WITH A CYTOTOXIC EFFECT | |
EP0790305B1 (en) | Mutant human growth hormones and their uses | |
Jelkmann | Erythropoiesis stimulating agents and techniques: a challenge for doping analysts | |
KR0150000B1 (en) | Genes coding for a protein having human macif activity, expression vectors containing said genes trans formant geues, trans formant cells | |
US11628206B2 (en) | Method for inhibiting STAT3 activity comprising administering Ssu72 | |
Vosatka et al. | Dynamic interactions of c‐fos protein in serum‐stimulated 3T3 cells | |
Stebbing | Proteins as Therapeutics: Potential and Problems | |
CN109328194B (en) | Fusion proteins comprising CCL3 variants and uses thereof | |
US8066981B2 (en) | Compositions and methods related to toll-like receptor-3 | |
JPH07505524A (en) | IFN receptor recognition factor, its protein sequence and method of use | |
US20040171825A1 (en) | Human fibroblast growth factor-related compositions | |
EP2094726B1 (en) | Compositions and methods related to toll-like receptor-3 | |
JPH1156378A (en) | Variant human growth hormone and its use | |
JP2002509693A (en) | Cadherin-derived growth factor and uses thereof | |
CA2191321A1 (en) | Gene coding for modified bone morphogenic protein receptor | |
Materi et al. | Proteins: Hormones, Enzymes, and Monoclonal Antibodies—Background | |
KR102256159B1 (en) | C omposition for preventing and treating autoimmune diseases comprising Gastrokine 1 | |
EP0399777A2 (en) | Hematopoietic growth factor derived from T lymphocytes and methods of use therefor | |
Stebbing | Development of biological agents through DNA technology |